These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24632418)

  • 1. Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma.
    Mansour MA; Aljoufi MA; Al-Hosaini K; Al-Rikabi AC; Nagi MN
    Chem Biol Interact; 2014 May; 215():17-24. PubMed ID: 24632418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible antineoplastic potential of selective, irreversible proteasome inhibitor, carfilzomib on chemically induced hepatocarcinogenesis in rats.
    Mansour MA; Aljoufi MA; Al-Hosaini K; Al-Rikabi AC; Nagi MN
    J Biochem Mol Toxicol; 2014 Sep; 28(9):400-6. PubMed ID: 24861196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Nasr M; Selima E; Hamed O; Kazem A
    Eur J Pharmacol; 2014 Jan; 723():267-75. PubMed ID: 24291100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway.
    Hsu YL; Kuo PL; Cho CY; Ni WC; Tzeng TF; Ng LT; Kuo YH; Lin CC
    Food Chem Toxicol; 2007 Jul; 45(7):1249-57. PubMed ID: 17316946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1,2,4-triazole derivatives as antitumor agents against hepatocellular carcinoma.
    Radwan RR; Zaher NH; El-Gazzar MG
    Chem Biol Interact; 2017 Aug; 274():68-79. PubMed ID: 28693887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginger ingredients inhibit the development of diethylnitrosoamine induced premalignant phenotype in rat chemical hepatocarcinogenesis model.
    Mansour MA; Bekheet SA; Al-Rejaie SS; Al-Shabanah OA; Al-Howiriny TA; Al-Rikabi AC; Abdo AA
    Biofactors; 2010; 36(6):483-90. PubMed ID: 20872761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.
    Mansour MA; Al-Ismaeel H; Al-Rikabi AC; Al-Shabanah OA
    Life Sci; 2011 Aug; 89(5-6):188-94. PubMed ID: 21699905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo attenuation of angiogenesis in hepatocellular carcinoma by Nigella sativa.
    Fathy M; Nikaido T
    Turk J Med Sci; 2018 Feb; 48(1):178-186. PubMed ID: 29479981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
    Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL
    J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats.
    Saleem S; Shaharyar MA; Khusroo MJ; Ahmad P; Rahman RU; Ahmad K; Alam MJ; Al-Harbi NO; Iqbal M; Imam F
    Mol Cell Biochem; 2013 Dec; 384(1-2):147-53. PubMed ID: 24026428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
    Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
    J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.
    Elewa MA; Al-Gayyar MM; Schaalan MF; Abd El Galil KH; Ebrahim MA; El-Shishtawy MM
    Clin Exp Metastasis; 2015 Jun; 32(5):479-93. PubMed ID: 25999065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis.
    Cong M; Liu T; Wang P; Fan X; Yang A; Bai Y; Peng Z; Wu P; Tong X; Chen J; Li H; Cong R; Tang S; Wang B; Jia J; You H
    Am J Pathol; 2013 May; 182(5):1607-16. PubMed ID: 23474083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
    Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
    Mise M; Arii S; Higashituji H; Furutani M; Niwano M; Harada T; Ishigami S; Toda Y; Nakayama H; Fukumoto M; Fujita J; Imamura M
    Hepatology; 1996 Mar; 23(3):455-64. PubMed ID: 8617424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-irradiated β-glucan modulates signaling molecular targets of hepatocellular carcinoma in rats.
    Elsonbaty SM; Zahran WE; Moawed FS
    Tumour Biol; 2017 Aug; 39(8):1010428317708703. PubMed ID: 28810822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis.
    Bishayee A; Thoppil RJ; Darvesh AS; Ohanyan V; Meszaros JG; Bhatia D
    J Nutr Biochem; 2013 Jan; 24(1):178-87. PubMed ID: 22841394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
    Saber S; Mahmoud AAA; Goda R; Helal NS; El-Ahwany E; Abdelghany RH
    Toxicol Lett; 2018 Oct; 295():32-40. PubMed ID: 29859236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.